Ocular Therapeutix, Inc. Appoints Two New Board Members
Ocular Therapeutix, Inc. announced today the expansion of its board of directors with the appointment of Mr. Daniel Myers and
Pioneering Medical Innovations
Pioneering Medical Innovations
Ocular Therapeutix, Inc. announced today the expansion of its board of directors with the appointment of Mr. Daniel Myers and
I-Therapeutix, Inc. announced today that it has changed its corporate name to Ocular Therapeutix, Inc. Amar Sawhney, President and CEO-stated
In Vivo interviews device entrepreneur Amar Sawhney whose engineering background led him to Focal Inc. There Sawhney advanced important developments
I-Therapeutix announced today that it has closed a $15million dollar Series C financing. The round was led by Polaris Venture
In Vivo interviews device entrepreneur Fred Khosravi about his secrets for success in medical device company creation. Khosravi was part
Located on opposite coasts and with complementary skill sets, Fred Khosravi, founder of EndoTex, teamed up with Amar Sawhney, founder
Sometimes just getting FDA approval isn’t enough. AccessClosure got FDA clearance of its PMA vascular closure device, only to delay
I-Therapeutix, Inc. announced today that Mr. Richard Packard and Dr. Daniel Calladine from the Prince Charles Eye Unit, King Edward
Vendors selected for the “Cool Vendor report” are innovative, impactful and intriguing Mountain View, California March 23, 2009 – NextPlane,
Strategic acquisition to expand Cognizant’s Life Sciences industry offerings PRNewswire-FirstCall – TEANECK, N.J. Cognizant Technology Solutions Corporation (NASDAQ: CTSH), a